The evolving role of systemic therapy in melanoma: Treatment and toxicities | 61 min

User Avatar
(0 review)
Free
mia_thumb_nurse_conference_2019_03

You have 1 hour 1 minute remaining for the module

  • The evolving role of systemic therapy in melanoma: Treatment and toxicities | 61 min 0/1

    take Module

    Medical oncology has changed the way melanoma is treated and continues to evolve. Medical Oncologist A/Prof Carlino provides an overview of how targeted therapies and immunotherapies are being used in the treatmement of advanced melanoma. He also briefly mentions their use as adjuvant therapy. Our Clinical Nurse Consultants then discuss the importance of the nursing role in assessment and management of side effects from these treatments.

    PRESENTERS
    A/Prof Matteo Carlino
    Medical Oncologist, Melanoma Institute Australia, Westmead and Blacktown Hospitals | Clinical Associate Professor, The University of Sydney

    Rebecca Johnson
    Clinical Nurse Consultant, Melanoma Institute Australia

    Kate Willis
    Clinical Nurse Consultant, Melanoma Institute Australia

    ACCREDITATION
    Coming soon

    LEARNING OUTCOMES
    1. Describe the impact that targeted therapies and immunotherapies are having on the health outcomes and survival, of patients with advanced melanoma including the use of adjuvant therapy, understanding the mechanism of action of these new treatments and their respective toxicity profiles.
    2. List the best practice recommendations in the nursing role in assessment and management of side effects from these treatments.

    This learning module was proudly supported through unrestricted educational grants from:

Reviews

Average Rating

0
0 rating

Detailed Rating

5 Star
0%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Free